| mRNA |
BRD-K37390332 |
CTRPv2 |
pan-cancer |
AAC |
-0.0053 |
0.9 |
| mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0047 |
0.9 |
| mRNA |
SNX-2112 |
GDSC1000 |
pan-cancer |
AAC |
0.0041 |
0.9 |
| mRNA |
BRD-K96431673 |
CTRPv2 |
pan-cancer |
AAC |
-0.0094 |
0.9 |
| mRNA |
PD-0332991 |
CCLE |
pan-cancer |
AAC |
-0.0057 |
0.9 |
| mRNA |
erismodegib |
CTRPv2 |
pan-cancer |
AAC |
-0.0046 |
0.9 |
| mRNA |
AG-014699 |
GDSC1000 |
pan-cancer |
AAC |
-0.0042 |
0.9 |
| mRNA |
selumetinib:GDC-0941 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0043 |
0.9 |
| mRNA |
HLI 373 |
CTRPv2 |
pan-cancer |
AAC |
0.0043 |
0.9 |
| mRNA |
Sorafenib |
CCLE |
pan-cancer |
AAC |
-0.0052 |
0.9 |